bioRxiv ScienceSearch

bioRxiv · 10.1101/725952

Frequency of five Escherichia Coli pathotypes in Iranian adults and children with acute diarrhea

Abstract

Backgroundknowledge about the distribution of Escherichia Coli (E. coli) pathotypes in Iran is limited to studies with small scale and limited scope. This nation-wide survey aims to provide a more generalizable estimate of pathogenic E. coli distribution in Iran.\n\nMethodsDuring January 2013 and January 2014, stool samples were collected from 1306 acute diarrhea cases of 15 provinces. Culture-positive E. coli samples were tested with PCR for detection of five E. coli pathotypes (STEC, ETEC, EPEC, EAEC, and EIEC). Frequency of these pathotypes was estimated for different provinces, age groups, and months/seasons.\n\nResultsOf 1305 diarrheal samples, 979 were E. coli-positive (prevalence: 75.0%; 95% CI: 72.6, 77.3%). Pathogenic E. coli was detected in 659 diarrheal samples (prevalence: 50.5%; 95% CI: 47.8, 53.2%). STEC and EIEC was the most and the least frequent pathotypes (35.4% and 0.3%, respectively). ETEC (14.0%) and EPEC (13.1%) were the second and the third frequent pathotypes, respectively. EAEC was not highly prevalent (4.3%). Fars and Razavi Khorasan provinces had the highest and lowest frequencies (88.7% and 34.8%, respectively). E. coli pathotypes were more frequent in warmer (i.e., spring and summer) than cooler (i.e., fall and winter) seasons. The highest frequency of pathogenic E. coli was observed in infants and children under 5 years (73% each). There was no association between sex and pathogenic E. coli infection.\n\nConclusionsDiarrheagenic E. coli may be an important cause of acute diarrhea in adults and children in Iran. STEC and ETEC seem to be widespread and show a peak in warmer seasons. This finding could impact the recommended use of STEC and ETEC vaccines during warmer seasons, especially for infants, young children and elderlies. Monitoring the rate of diarrheagenic E. coli infection, E. coli serotypes, and their antibiotic resistance is recommended for evaluations of time-trends and effectiveness of interventions.\n\nAuthor summaryEscherichia coli, also known as E. coli is a bacterium of the genus Escherichia that is normally found in the lower intestine of human. Most E. coli strains are harmless, but some can cause infection in the gastrointestinal tract, causing diarrhea. These pathogenic E. coli strains are classified based on their mechanism of pathogenesis. In this regard, five important E. coli strains include Shiga toxin-producing E. coli (STEC), enterotoxigenic E. coli (ETEC), enteropathogenic E. coli (EPEC), enteroaggregative E. coli (EAEC), and enteroinvasive E. coli (EIEC). In a national survey conducted in Jan 2013 till Jan 2014, we collected 1305 diarrheal samples from 15 (out of 31) provinces of Iran. Of these, 979 samples (75%) were E. coli-positive in the culture test. Molecular tests showed that 659 samples were pathogenic E. coli, suggesting that 50.5% of the diarrhea cases were induced due to pathogenic E. coli infection. The most prevalent pathogenic E. coli strains in Iran were STEC (35.4%) and ETEC (0.3%), and were more commonly detected in warmer seasons, infants, and children less than five years. So, the use of vaccines, especially for STEC and ETEC, during warmer seasons and for infants, young children and elderlies are recommended.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Eybpoosh, S., Mostaan, S., Gouya, M. M., Masoumi-Asl, H., Owlia, P., Eshrati, B., Montazer Razavi Khorasan, M. R., Bouzari, S.. 2019-08-05. Frequency of five Escherichia Coli pathotypes in Iranian adults and children with acute diarrhea. https://doi.org/10.1101/725952

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology